No abstract available
Keywords:
Africa; Covid-19; SARS-cov-2; azithromycin; hydroxychloroquine.
PubMed Disclaimer
References
-
-
Lalaoui R., Bakour S., Raoult D., Verger P., Sokhna C., Devaux C., et al. What could explain the late emergence of COVID-19 in Africa? New Microbe. New Infect. 2020 Nov;38:100760. doi: 10.1016/j.nmni.2020.100760.
-
DOI
-
PMC
-
PubMed
-
-
Gautret P., Million M., Jarrot P.A., Camoin-Jau L., Colson P., Fenollar F., et al. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 Dec;16(12):1159–1184. doi: 10.1080/1744666X.2021.1847640.
-
DOI
-
PubMed
-
-
Anglemyer A., Horvath H.T., Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev. 2014 Apr 29;(4) doi: 10.1002/14651858.MR000034.pub2. MR000034.
-
DOI
-
PMC
-
PubMed
-
-
Million M., Lagier J.C., Tissot-Dupont H., Ravaux I., Dhiver C., Tomei C., et al. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients. Rev Cardiovasc Med. 2021 Sep 24;22(3):1063–1072. doi: 10.31083/j.rcm2203116. PMID: 34565108.
-
DOI
-
PubMed
-
-
Colson P., Parola P., Raoult D. The emergence, dynamics and significance of SARS-CoV-2 variants. New Microbe. New Infect. 2022 Jan;45:100962. doi: 10.1016/j.nmni.2022.100962. Epub 2022 Feb 1. PMID: 35127101; PMCID: PMC8806113.
-
DOI
-
PMC
-
PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous